Some hormone-blocking drugs may not be beneficial to the elderly prostate cancer patients.
Such were the findings of a new prostate cancer study.
A prostate cancer study that could change how doctors treat some patients found that widely used hormone-blocking drugs did not improve survival chances for older men whose disease hadn’t spread.
In fact, men given the drugs alone were slightly more likely to die of prostate cancer during the next six years than men who’d gotten medical monitoring but no or delayed treatment, another common treatment approach.
The study involved nearly 20,000 Medicare patients with prostate cancer that hadn’t spread. A surprising …read more